S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
CNSX:AMS

American Shared Hospital Services Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
American Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers in the United States. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides image guided radiation therapy systems that integrate imaging and detection components into an accelerator, which allows clinicians to plan treatment, verify positioning, and deliver treatment. In addition, the company offers financing services for Leksell Gamma Knife units. Further, it provides proton beam therapy equipment and services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. As of March 1, 2018, it operated 16 Gamma Knife units, as well as served 17 medical centers in 15 states of the United States. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

MarketRank

Overall MarketRank

0.62 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Specialized Health Services
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone415-788-5300
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive AMS News and Ratings via Email

Sign-up to receive the latest news and ratings for AMS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











American Shared Hospital Services (CNSX:AMS) Frequently Asked Questions

What stocks does MarketBeat like better than American Shared Hospital Services?

Wall Street analysts have given American Shared Hospital Services a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but American Shared Hospital Services wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of American Shared Hospital Services' key competitors?

Who are American Shared Hospital Services' key executives?

American Shared Hospital Services' management team includes the following people:
  • Dr. Ernest A. Bates, Founder, Chairman & CEO (Age 82)
  • Mr. Craig K. Tagawa, Sr. VP, Chief Operating & Financial Officer (Age 65)
  • Mr. Ernest R. Bates, VP of Sales & Bus. Devel. (Age 52)
  • Mr. Willie R. Barnes, Corp. Sec. (Age 87)
  • Ms. Alexis Wallace, Controller

What is American Shared Hospital Services' stock symbol?

American Shared Hospital Services trades on the CNSX under the ticker symbol "AMS."

How do I buy shares of American Shared Hospital Services?

Shares of AMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is American Shared Hospital Services' official website?

The official website for American Shared Hospital Services is www.ashs.com.

How can I contact American Shared Hospital Services?

The company can be reached via phone at 415-788-5300.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.